BIOSECURing the Future: What an American Cold War with China Could Mean for the Pharma Industry

 
• By Nielsen Hobbs

Whether the legislation aimed at discouraging use of Chinese contractors passes in its current form or not, industry will continue to face more pressure to decouple its operations.

Pharma could suffer some blows as conflict between the U.S. and China intensifies. (Shutterstock)

More from Legislation

More from North America